Alpha1-Proteinase Inhibitor (human plasma-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alpha1-Proteinase Inhibitor (human plasma-derived), covering 2018-04-19 to 2018-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus [Phase 2]